Karin Badel

Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection

Dominique Schols, M. Lederman, C. Flexner, 2004, Journal of acquired immune deficiency syndromes.

Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1.

Edwin DeJesus, M. Boffito, R. Wong, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.

J. Dipersio, J. Liesveld, S. Devine, 2005, Blood.